Using Plasma to Treat Rare Diseases

Giles Platford, president of the Plasma-Derived Therapies Business Unit at Takeda, discusses its work in plasma-derived therapies, its recently approved therapy for the rare neuromuscular condition CIDP, and what issues need to be addressed to ensure an adequate supply of human plasma for therapeutic applications.